[{"data":1,"prerenderedAt":391},["ShallowReactive",2],{"drug-cephalexin":3},{"id":4,"schemaVersion":5,"name":6,"category":9,"class":10,"brands":13,"synonyms":17,"formulations":20,"regimens":62,"contraindications":175,"warnings":195,"renal":224,"monitoring":234,"interactions":235,"review":252,"examples":255,"atc":283,"iran":285,"links":333,"populations":353,"usApproval":386},"cephalexin",1,{"fa":7,"en":8},"سفالکسین","Cephalexin","anti-infectives",{"fa":11,"en":12},"سفالوسپورین نسل اول","First-generation cephalosporin",[14],{"name":15,"market":16},"Keflex","US",[18,19,7],"cefalexin","کفلکس",[21,35,43,54],{"id":22,"form":23,"route":24,"label":25,"concentration":26,"markets":30,"refs":31},"susp-125-5","suspension","oral","125 mg \u002F 5 mL",{"amount":27,"unit":28,"perVolumeMl":29},125,"mg",5,[16],[32],{"source":33,"section":34},"fda-cephalexin-susp","3",{"id":36,"form":23,"route":24,"label":37,"concentration":38,"markets":40,"refs":41},"susp-250-5","250 mg \u002F 5 mL",{"amount":39,"unit":28,"perVolumeMl":29},250,[16],[42],{"source":33,"section":34},{"id":44,"form":45,"route":24,"label":46,"concentration":47,"markets":49,"refs":50},"cap-250","capsule","250 mg capsule",{"amount":39,"unit":28,"perUnit":45,"scored":48},false,[16],[51],{"source":52,"section":53},"fda-cephalexincap","How Supplied",{"id":55,"form":45,"route":24,"label":56,"concentration":57,"markets":59,"refs":60},"cap-500","500 mg capsule",{"amount":58,"unit":28,"perUnit":45,"scored":48},500,[16],[61],{"source":52,"section":53},[63,89,110,131,156],{"id":64,"disease":65,"label":66,"population":69,"type":74,"unit":28,"dose":75,"refs":79,"notes":82},"aom","acute-otitis-media",{"fa":67,"en":68},"اوتیت مدیا — ۷۵ تا ۱۰۰ mg\u002Fkg\u002Fday، هر ۶ ساعت","Otitis media — 75–100 mg\u002Fkg\u002Fday, every 6 h",{"minAge":70,"maxAge":72},{"value":5,"unit":71},"year",{"value":73,"unit":71},15,"weightBased",{"perKgPerDay":76,"perKgPerDayMax":77,"dividedDoses":78},75,100,4,[80],{"source":33,"section":81},"2.2",[83],{"text":84,"refs":87},{"fa":85,"en":86},"مدت درمان ۷ تا ۱۴ روز؛ برای عفونت استرپتوکوک بتاهمولیتیک حداقل ۱۰ روز.","Treat 7 to 14 days; at least 10 days for beta-hemolytic streptococcal infection.",[88],{"source":33,"section":81},{"id":90,"disease":91,"label":92,"population":95,"type":74,"unit":28,"dose":98,"refs":101,"notes":105},"usual-q6","skin-soft-tissue-infection",{"fa":93,"en":94},"عفونت پوست، تنفسی، ادراری، استخوان — ۲۵ تا ۵۰ mg\u002Fkg\u002Fday، هر ۶ ساعت","Skin, respiratory, GU, bone — 25–50 mg\u002Fkg\u002Fday, every 6 h",{"minAge":96,"maxAge":97},{"value":5,"unit":71},{"value":73,"unit":71},{"perKgPerDay":99,"perKgPerDayMax":100,"dividedDoses":78},25,50,[102,103],{"source":33,"section":81},{"source":33,"section":104},"2.2, Table 1",[106],{"text":107,"refs":108},{"fa":85,"en":86},[109],{"source":33,"section":81},{"id":111,"disease":91,"label":112,"population":115,"type":74,"unit":28,"dose":118,"refs":120,"notes":126},"usual-q12",{"fa":113,"en":114},"عفونت پوست، تنفسی، ادراری، استخوان — ۲۵ تا ۵۰ mg\u002Fkg\u002Fday، هر ۱۲ ساعت","Skin, respiratory, GU, bone — 25–50 mg\u002Fkg\u002Fday, every 12 h",{"minAge":116,"maxAge":117},{"value":5,"unit":71},{"value":73,"unit":71},{"perKgPerDay":99,"perKgPerDayMax":100,"dividedDoses":119},2,[121,122],{"source":33,"section":81},{"source":33,"section":104,"note":123},{"fa":124,"en":125},"گزینه ۲: دو بار در روز","Option 2: two times a day",[127],{"text":128,"refs":129},{"fa":85,"en":86},[130],{"source":33,"section":81},{"id":132,"disease":133,"label":134,"population":137,"type":74,"unit":28,"dose":140,"refs":141,"limits":143,"notes":151},"severe","respiratory-tract-infection",{"fa":135,"en":136},"عفونت شدید — ۵۰ تا ۱۰۰ mg\u002Fkg\u002Fday، هر ۶ ساعت","Severe infection — 50–100 mg\u002Fkg\u002Fday, every 6 h",{"minAge":138,"maxAge":139},{"value":5,"unit":71},{"value":73,"unit":71},{"perKgPerDay":100,"perKgPerDayMax":77,"dividedDoses":78},[142],{"source":33,"section":81},{"maxPerDay":144,"refs":145},4000,[146],{"source":33,"section":147,"note":148},"2.1",{"fa":149,"en":150},"حداکثر ۴ گرم در روز (بزرگسال)","Up to 4 g daily (adult maximum)",[152],{"text":153,"refs":154},{"fa":85,"en":86},[155],{"source":33,"section":81},{"id":157,"disease":158,"label":159,"population":162,"type":164,"unit":28,"dose":165,"refs":166,"notes":168},"adult","urinary-tract-infection",{"fa":160,"en":161},"بزرگسال و ۱۵ سال به بالا — ۲۵۰ mg هر ۶ ساعت","Adults and ≥15 years — 250 mg every 6 h",{"minAge":163},{"value":73,"unit":71},"fixed",{"perDose":39,"dosesPerDay":78},[167],{"source":33,"section":147},[169],{"text":170,"refs":173},{"fa":171,"en":172},"یا ۵۰۰ mg هر ۱۲ ساعت؛ در عفونت شدید تا ۴ گرم در روز در ۲ تا ۴ نوبت.","Or 500 mg every 12 h; for more severe infections up to 4 g daily in 2–4 doses.",[174],{"source":33,"section":147},[176,185],{"id":177,"severity":178,"text":179,"refs":182},"hypersensitivity","block",{"fa":180,"en":181},"حساسیت شناخته‌شده به سفالکسین یا سایر سفالوسپورین‌ها.","Known hypersensitivity to cephalexin or other cephalosporins.",[183],{"source":33,"section":184},"4",{"id":186,"severity":178,"rule":187,"text":189,"refs":192},"under-1-year",{"maxAge":188},{"value":5,"unit":71},{"fa":190,"en":191},"بی‌خطری و اثربخشی سوسپانسیون زیر ۱ سال ثابت نشده است.","Safety and effectiveness not established in pediatric patients younger than one year.",[193],{"source":33,"section":194},"8.4",[196,203,210,217],{"text":197,"refs":200},{"fa":198,"en":199},"واکنش‌های حساسیتی","Hypersensitivity reactions",[201],{"source":33,"section":202},"5.1",{"text":204,"refs":207},{"fa":205,"en":206},"اسهال مرتبط با کلستریدیوئیدس دیفیسیل","Clostridioides difficile-associated diarrhea",[208],{"source":33,"section":209},"5.2",{"text":211,"refs":214},{"fa":212,"en":213},"احتمال تشنج، به‌ویژه در نارسایی کلیه","Seizure potential",[215],{"source":33,"section":216},"5.4",{"text":218,"refs":221},{"fa":219,"en":220},"طولانی شدن زمان پروترومبین","Prolonged prothrombin time",[222],{"source":33,"section":223},"5.5",[225],{"egfrBelow":226,"severity":227,"text":228,"refs":231},30,"warn",{"fa":229,"en":230},"کلیرانس کمتر از ۳۰ (۱۵ سال به بالا): تنظیم دوز طبق جدول ۲ برچسب.","CrCl \u003C30 mL\u002Fmin (≥15 years): adjust per label Table 2.",[232],{"source":33,"section":233},"2.4",[],[236,244],{"with":237,"text":238,"refs":241},"metformin",{"fa":239,"en":240},"افزایش سطح متفورمین","Increased metformin exposure",[242],{"source":33,"section":243},"7.1",{"with":245,"text":246,"refs":249},"probenecid",{"fa":247,"en":248},"پروبنسید دفع کلیوی سفالکسین را مهار می‌کند","Probenecid inhibits renal excretion of cephalexin",[250],{"source":33,"section":251},"7.2",{"status":253,"reviewer":254,"date":254},"unverified",null,[256,263,267,270,274,278],{"regimen":64,"formulation":36,"input":257,"expect":260},{"ageYears":258,"weightKg":259},3,10,{"perDose":261,"mlPerDose":262,"upperPerDose":39,"upperMlPerDose":29},187.5,3.75,{"regimen":90,"formulation":36,"input":264,"expect":266},{"ageYears":29,"weightKg":265},20,{"perDose":27,"upperPerDose":39},{"regimen":111,"formulation":36,"input":268,"expect":269},{"ageYears":29,"weightKg":265},{"perDose":39,"upperPerDose":58},{"regimen":132,"formulation":36,"input":271,"expect":273},{"ageYears":272,"weightKg":100},14,{"upperPerDay":144},{"regimen":157,"formulation":36,"input":275,"expect":277},{"ageYears":226,"weightKg":276},70,{"perDose":39,"mlPerDose":29},{"regimen":64,"formulation":36,"input":279,"expect":281},{"ageMonths":280,"weightKg":280},8,{"status":282},"blocked",[284],"J01DB01",{"status":286,"forms":287,"refs":328},"registered",[288,292,296,300,304,308,312,316,320,324],{"code":289,"en":290,"fa":291},"00242","CEFALEXIN 125MG\u002F5ML 100ML POW FOR SUSP","پودر برای تهیه سوسپانسیون خوراکی سفالکسین ۱۲۵ میلی‌گرم \u002F ۵ میلی‌لیتر ۱۰۰ میلی‌لیتر",{"code":293,"en":294,"fa":295},"00241","CEFALEXIN 125MGR\u002FSACHET","ساشه سفالکسین ۱۲۵ MGR",{"code":297,"en":298,"fa":299},"00243","CEFALEXIN 250MG CAP","کپسول سفالکسین ۲۵۰ میلی‌گرم",{"code":301,"en":302,"fa":303},"00246","CEFALEXIN 250MG\u002F5ML 100ML POW FOR SUSP","پودر برای تهیه سوسپانسیون خوراکی سفالکسین ۲۵۰ میلی‌گرم \u002F ۵ میلی‌لیتر ۱۰۰ میلی‌لیتر",{"code":305,"en":306,"fa":307},"00244","CEFALEXIN 250MGR\u002FSACHET","ساشه سفالکسین ۲۵۰ MGR",{"code":309,"en":310,"fa":311},"00245","CEFALEXIN 500MG CAP","کپسول سفالکسین ۵۰۰ میلی‌گرم",{"code":313,"en":314,"fa":315},"15724","CEFALEXIN 500MG TAB","قرص سفالکسین ۵۰۰ میلی‌گرم",{"code":317,"en":318,"fa":319},"00240","CEFALEXIN DROP","قطره سفالکسین",{"code":321,"en":322,"fa":323},"52391","CEFALEXIN POWDER ORAL 125 mg","پودر سفالکسین ۱۲۵ میلی‌گرم",{"code":325,"en":326,"fa":327},"53055","CEFALEXIN POWDER, FOR SUSPENSION ORAL 125 mg\u002F5mL 30 mL","سوسپانسیون خوراکی سفالکسین ۱۲۵ میلی‌گرم \u002F ۵ میلی‌لیتر ۳۰ میلی‌لیتر",[329],{"source":330,"section":331,"url":332},"darooyab-generic","G-311\u002FCephalexin","https:\u002F\u002Fwww.darooyab.ir\u002FG-311\u002FCephalexin",[334,338,342,345,348,351],{"kind":335,"url":336,"label":337},"fda","https:\u002F\u002Fwww.accessdata.fda.gov\u002Fscripts\u002Fcder\u002Fdaf\u002Findex.cfm?event=overview.process&ApplNo=062703","ANDA062703",{"kind":339,"url":340,"label":341},"dailymed","https:\u002F\u002Fdailymed.nlm.nih.gov\u002Fdailymed\u002FdrugInfo.cfm?setid=5858b90a-a80d-40b4-9275-b89e9121ea42","FDA Cephalexin",{"kind":339,"url":343,"label":344},"https:\u002F\u002Fdailymed.nlm.nih.gov\u002Fdailymed\u002FdrugInfo.cfm?setid=8e28f049-6110-4473-830f-c494191a7197","FDA Cephalexin caps",{"kind":346,"url":347,"label":8},"medlineplus","https:\u002F\u002Fmedlineplus.gov\u002Fdruginfo\u002Fmeds\u002Fa682733.html",{"kind":349,"url":350,"label":284},"who-atc","https:\u002F\u002Fatcddd.fhi.no\u002Fatc_ddd_index\u002F?code=J01DB01",{"kind":352,"url":332,"label":8},"darooyab",{"pregnancy":354,"lactation":363,"pediatric":371,"geriatric":378},{"level":355,"text":356,"quote":359,"refs":360},"caution",{"fa":357,"en":358},"برچسب خطر مشخصی برای بارداری ذکر نکرده یا داده کافی ندارد؛ فقط در صورت لزوم و با نظر پزشک.","Label states no clear risk or has limited data; use only if needed, under medical advice.","Risk Summary Available data from published epidemiologic studies and pharmacovigilance case reports over several decades cephalexin for oral suspension use in pregnant women have not established drug-associated risks of major birth defects, miscarriage, or adverse maternal or fetal outcomes.",[361],{"source":33,"section":362},"8.1",{"level":355,"text":364,"quote":367,"refs":368},{"fa":365,"en":366},"برچسب: در شیردهی با احتیاط؛ متن برچسب را ببینید.","Label: use with caution while breastfeeding; see the label text.","Risk Summary Data from a published clinical lactation study report that cephalexin is present in human milk.",[369],{"source":33,"section":370},"8.2",{"level":355,"text":372,"quote":375,"refs":376},{"fa":373,"en":374},"برچسب برای کودکان شرط، محدودیت سنی یا نکته دارد؛ جمله برچسب در زیر آمده است.","The label has conditions, age limits or notes for children; the label sentence is quoted below.","The safety and effectiveness of cephalexin for oral suspension have been established in pediatric patients aged one year and older in clinical trials [see Indications and Usage ( 1.1 - 1.5 )] for the dosages described in the dosage and administration section [see Dosage and Administration ( 2.1 , 2.2 )].",[377],{"source":33,"section":194},{"level":355,"text":379,"quote":382,"refs":383},{"fa":380,"en":381},"برچسب: در سالمندان با احتیاط و معمولاً از دوز پایین شروع شود.","Label: use with caution in older adults, usually starting at the low end of the dose range.","Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection [see Warnings and Precautions ( 5.4 )].",[384],{"source":33,"section":385},"8.5",{"kind":387,"refs":388,"id":337},"ANDA",[389],{"source":33,"section":390},"SPL approval \u002F marketing category",1792191872277]